Stem Cell Extracellular Vesicles as Anti-SARS-CoV-2 Immunomodulatory Therapeutics: A Systematic Review of Clinical and Preclinical Studies.
Sarah Hamdy AhmedMohamed Atef AlMoslemanyKenneth Whitaker WitwerAhmed Gamal TehamyNagwa El-BadriPublished in: Stem cell reviews and reports (2024)
Similar to their parental cells, stem cell EVs mediate lung tissue regeneration by targeting multiple pathways and thus hold promise in promoting the recovery of COVID-19 patients and improving the survival rate of severely affected patients.
Keyphrases
- stem cells
- sars cov
- end stage renal disease
- induced apoptosis
- ejection fraction
- newly diagnosed
- cell therapy
- chronic kidney disease
- prognostic factors
- peritoneal dialysis
- small molecule
- cell cycle arrest
- free survival
- endoplasmic reticulum stress
- big data
- cell proliferation
- bone marrow
- mesenchymal stem cells
- case control
- pi k akt